Subhealth: Definition, criteria for diagnosis and potential prevalence in the central region of China

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Li, Guolin ^a   Xie, Fuxia ^a   Yan, Siyu ^a   Hu, Xiaofei ^a   Jin, Bo ^a   Wang, Jun ^a   Wu, Jinfeng ^a   Yin, Dazhong ^a,b   Xie, Qingji ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Disease; Health; Oxidative stress; Subhealth; Thiobarbituric acid reactive substances (TBARS)

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGE; AGED; BODY MASS; CHINA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; EPIDEMIOLOGY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH STATUS INDICATOR; HUMAN; MALE; MIDDLE AGED; NOMENCLATURE; OXIDATIVE STRESS; PHYSIOLOGY; PUBLIC HEALTH; QUESTIONNAIRE; RISK ASSESSMENT; SLEEP; VERY ELDERLY; YOUNG ADULT; ARTICLE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES AND PROCEDURES; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PUBLIC HEALTH; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; RISK ASSESSMENT; SLEEP; TERMINOLOGY AS TOPIC; YOUNG ADULT;

EID: 84876978183     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-446     Document Type: Article

References (44)

1. The metabolic syndrome-a new worldwide definition. Alberti KG, Zimmet P, Shaw J, Lancet 2005 366 9491 1059 1062 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
2. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Alberti KG, Zimmet PZ, Diabet Med 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0. CO;2-S 9686693 (Pubitemid 28319935)
3. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart A, National Heart L, Blood I, Circulation 2004 109 3 433 438 10.1161/01.CIR.0000111245.75752.C6 14744958 (Pubitemid 38133916)
4. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the adult treatment panel III and the international diabetes federation in united states american and european populations. Assmann G, Guerra R, Fox G, Cullen P, Schulte H, Willett D, Grundy SM, Am J Cardiol 2007 99 4 541 548 10.1016/j.amjcard.2006.08.045 17293200 (Pubitemid 46215539)
5. Heart disease and stroke statistics-2013 update: a report from the American heart association. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Circulation 2013 127 1 6 e245 10.1161/CIR.0b013e31828124ad 23239837
6. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Alberti KG, Zimmet P, Shaw J, Diabet Med 2006 23 5 469 480 10.1111/j.1464-5491.2006.01858.x 16681555
7. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E, Diabetes Metab 2002 28 5 364 376 12461473 (Pubitemid 35434310)
8. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Expert Panel on Detection E, Treatment of High Blood Cholesterol in A, JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
9. American College of Endocrinology position statement on the insulin resistance syndrome. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Endocr Pract 2003 9 3 237 252 12924350
10. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Third Report of the National Cholesterol Education Program (NCEP), Circulation 2002 106 25 3143 3421 12485966
11. Metabolic syndrome-what is the clinical usefulness? Kahn R, Lancet 2008 371 9628 1892 1893 10.1016/S0140-6736(08)60731-X 18501420
12. The metabolic syndrome: time for a critical appraisal: joint statement from the american diabetes association and the european association for the study of diabetes. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D, Diabetes Care 2005 28 9 2289 2304 10.2337/diacare.28.9.2289 16123508 (Pubitemid 41242486)
13. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lancet 2008 371 9628 1927 1935 10.1016/S0140-6736(08)60602-9 18501419
14. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
15. Hormesis, allostatic buffering capacity and physiological mechanism of physical activity: a new theoretic framework. Li G, He H, Med Hypotheses 2009 72 5 527 532 10.1016/j.mehy.2008.12.037 19211194
16. Physiology and neurobiology of stress and adaptation: central role of the brain. McEwen BS, Physiol Rev 2007 87 3 873 904 10.1152/physrev.00041.2006 17615391 (Pubitemid 47086281)
17. Protective and damaging effects of stress mediators. McEwen BS, N Engl J Med 1998 338 3 171 179 10.1056/NEJM199801153380307 9428819 (Pubitemid 28041866)
18. Mitochondrial defects may play role in the metabolic syndrome. Hampton T, JAMA 2004 292 23 2823 2824 10.1001/jama.292.23.2823 15598899 (Pubitemid 39628223)
19. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr, JAMA 2008 299 19 2287 2293 10.1001/jama.299.19.2287 18492970 (Pubitemid 351724395)
20. The free radical theory of aging matures. Beckman KB, Ames BN, Physiol Rev 1998 78 2 547 581 9562038 (Pubitemid 28182903)
21. The essential mechanisms of aging: Irreparable damage accumulation of biochemical side-reactions. Yin DZ, Chen KJ, Exp Gerontol 2005 40 6 455 465 10.1016/j.exger.2005.03.012 15935593 (Pubitemid 40884498)
22. Principles of blood collection. Turgeon ML, Clinical hematology: theory and procedures Philadelphia: Lippincott Williams & Wilkins, Turgeon ML, 4 2004 18 40
23. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. WHO-Expert-Consultation, Lancet 2004 363 9403 157 163 14726171
24. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, JAMA 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
25. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the australian diabetes, obesity, and lifestyle study (AusDiab). Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Circulation 2007 116 2 151 157 10.1161/CIRCULATIONAHA.106.685628 17576864 (Pubitemid 47057520)
26. A new equation to estimate glomerular filtration rate. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Ann Intern Med 2009 150 9 604 612 10.7326/0003-4819-150-9- 200905050-00006 19414839
27. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
28. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Finney H, Newman DJ, Price CP, Ann Clin Biochem 2000 37 Pt 1 49 59 10672373 (Pubitemid 30064225)
29. Nonalcoholic fatty liver disease. Angulo P, N Engl J Med 2002 346 16 1221 1231 10.1056/NEJMra011775 11961152 (Pubitemid 34984585)
30. Chronic hepatitis B. Lok AS, McMahon BJ, Hepatology 2007 45 2 507 539 10.1002/hep.21513 17256718 (Pubitemid 46374607)
31. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Siest G, Schiele F, Galteau M-M, Panek E, Steinmetz J, Fagnani F, Gueguen R, Clin Chem 1975 21 8 1077 1087 1137913
32. Does carbonyl stress cause increased blood viscosity during storage? Li G, He H, Yan H, Zhao Q, Yin D, Clin Hemorheol Microcirc 2010 44 2 145 154 20203369
33. Procedures for detecting outlying observations in samples. Grubbs F, Technometrics 1969 11 1 1 21 10.1080/00401706.1969.10490657
34. Treating the metabolic syndrome. Bianchi C, Penno G, Romero F, Del Prato S, Miccoli R, Expert Rev Cardiovasc Ther 2007 5 3 491 506 10.1586/14779072.5.3. 491 17489673 (Pubitemid 46812959)
35. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. Rector RS, Warner SO, Liu Y, Hinton PS, Sun GY, Cox RH, Stump CS, Laughlin MH, Dellsperger KC, Thomas TR, Am J Physiol Endocrinol Metab 2007 293 2 500 506 10.1152/ajpendo.00116.2007 17473052 (Pubitemid 47205093)
36. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ, J Appl Physiol 2006 100 5 1657 1665 10.1152/japplphysiol. 01292.2005 16357066
37. Alcohol consumption and risk of stroke: a meta-analysis. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J, JAMA 2003 289 5 579 588 10.1001/jama.289.5.579 12578491 (Pubitemid 37428630)
38. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB, New Engl J Med 1993 328 8 538 545 10.1056/NEJM199302253280804 8426621 (Pubitemid 23053830)
39. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. Kottke TE, Battista RN, DeFriese GH, Brekke ML, JAMA 1988 259 19 2883 2889 10.1001/jama.259.19.2883 3367456
40. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC, N Engl J Med 2001 345 11 790 797 10.1056/NEJMoa010492 11556298
41. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D, JAMA 2004 292 12 1440 1446 10.1001/jama.292.12.1440 15383514 (Pubitemid 39258336)
42. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. Church TS, Earnest CP, Skinner JS, Blair SN, JAMA 2007 297 19 2081 2091 10.1001/jama.297.19.2081 17507344 (Pubitemid 46798166)
43. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Ford ES, Giles WH, Dietz WH, JAMA 2002 287 3 356 359 10.1001/jama.287.3.356 11790215 (Pubitemid 34251969)
44. Measurement of F-2-isoprostanes as an index of oxidative stress in vivo. Roberts LJ, Morrow JD, Free Radical Biol Med 2000 28 4 505 513 10.1016/S0891-5849(99)00264-6 (Pubitemid 30136031)